Key result
Right heart catheterization after decongestion was associated with a lower risk of heart failure readmission or all-cause mortality.
Why the study?
Initiating GDMT in hospitalized AHF patients remains challenging, and the impact of RHC performed after decongestion on GDMT optimization and patient prognosis is not well established.
Does right heart catheterization after decongestion improve guideline-directed medical therapy optimization and reduce heart failure readmission or all-cause mortality in patients hospitalized for acute heart failure?
Cohort (n=1,201)
Does right heart catheterization after decongestion improve guideline-directed medical therapy optimization and reduce heart failure readmission or all-cause mortality in patients hospitalized for acute heart failure?
Performing right heart catheterization after decongestion in acute heart failure patients facilitates GDMT optimization and is associated with a significant reduction in 1-year mortality and HF readmission.
Answers are grounded in this paper and cite their sources.
May support RHC post-decongestion for GDMT optimization in acute HF; leaves open confirmation in randomized trials.
Background The initiation of guideline-directed medical therapy (GDMT) in hospitalized patients with acute heart failure (AHF) remains challenging, particularly in determining the optimal timing and appropriateness of therapy. Right heart catheterization (RHC) performed after decongestion provides valuable hemodynamic insights; however, its impact on GDMT optimization and patient prognosis is not well established. Purpose This study aimed to evaluate whether hemodynamic assessment via RHC facilitates GDMT optimization, as measured by the Simple GDMT Score, and contributes to improved clinical outcomes. Methods We retrospectively analyzed 1,201 patients hospitalized for AHF between April 2015 and December 2023, excluding those with in-hospital mortality, dialysis dependence, heart failure with preserved ejection fraction (HFpEF), or early RHC. Patients were categorized into two groups: those who underwent RHC after decongestion (n=375) and those who did not (n=827). Propensity score matching was applied to balance baseline characteristics, resulting in 299 matched patients in each group. The primary outcome was the composite of heart failure (HF) readmission or all-cause mortality within one year. Secondary outcomes included HF readmission and all-cause mortality. Results The RHC group had a significantly higher Simple GDMT Score (5.1±2.3 vs. 4.5±2.1, p<0.05) and a higher initiation rate of the ‘Fantastic Four’ pharmacotherapies (20.4% vs. 10.4%, p=0.001), particularly with a significantly increased use of angiotensin receptor-neprilysin inhibitors (ARNI). The composite outcome of HF readmission or all-cause mortality was significantly lower in the RHC group (HR=0.536, 95% CI=0.370-0.778, p<0.01). Similarly, HF readmission (HR=0.54, 95% CI=0.35-0.81, p<0.01) and all-cause mortality (HR=0.43, 95% CI=0.18-0.99, p=0.048) were significantly reduced in the RHC group. Conclusions In patients hospitalized for AHF, RHC after decongestion facilitates the appropriate initiation and up-titration of GDMT, leading to improved clinical outcomes. These findings highlight the potential role of hemodynamic-guided GDMT optimization in enhancing the prognosis of AHF patients.
No takes yet. Share an insight, caveat, or question.
Matsukawa et al. (2025) conducted a cohort in Acute heart failure (n=1,201). Right heart catheterization (RHC) after decongestion vs. No RHC after decongestion was evaluated on Composite of heart failure readmission or all-cause mortality within one year (HR 0.536, 95% CI 0.370-0.778, p=<0.01). Right heart catheterization after decongestion was associated with a lower risk of heart failure readmission or all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: